TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 30 filers reported holding TRINITY BIOTECH PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $547,000 | -41.5% | 529,647 | -31.5% | 0.20% | -42.1% |
| Q3 2019 | $935,000 | -28.6% | 773,129 | -2.7% | 0.35% | -32.1% |
| Q2 2019 | $1,310,000 | -53.1% | 794,209 | -19.1% | 0.52% | -45.3% |
| Q1 2019 | $2,796,000 | +23.4% | 981,224 | -0.9% | 0.95% | +11.9% |
| Q4 2018 | $2,266,000 | -44.4% | 989,646 | -2.9% | 0.85% | -28.9% |
| Q3 2018 | $4,078,000 | -20.9% | 1,019,461 | -1.1% | 1.20% | -21.9% |
| Q2 2018 | $5,154,000 | -0.0% | 1,030,805 | +3.0% | 1.54% | +7.6% |
| Q1 2018 | $5,155,000 | -1.5% | 1,000,874 | -2.5% | 1.43% | -0.4% |
| Q4 2017 | $5,236,000 | -12.6% | 1,026,624 | -3.9% | 1.43% | -15.6% |
| Q3 2017 | $5,991,000 | -7.5% | 1,067,851 | -1.1% | 1.70% | -8.2% |
| Q2 2017 | $6,477,000 | +1.1% | 1,079,421 | +0.4% | 1.85% | -0.1% |
| Q1 2017 | $6,408,000 | +4.8% | 1,075,221 | +21.7% | 1.85% | +5.8% |
| Q4 2016 | $6,114,000 | – | 883,571 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |